DR. JUDITH A. WILIMAS, MD

Plain English
This study looked at how a new treatment approach for Wilms tumor, a type of kidney cancer in children, performed in patients in Central America. Out of 353 patients, 70% received chemotherapy before surgery, which helped reduce the size of tumors significantly, with 62% showing a partial response. The findings suggest that this method can make surgery safer and more effective for patients with advanced disease. Who this helps: This benefits pediatric cancer patients and their doctors by improving treatment options and outcomes.

Plain English
This study focused on how certain chemotherapy treatments affect kidney function in 12 children with high-risk Wilms tumor, a type of kidney cancer. Researchers found that kidney function, measured by a number called GFR, dropped by 7% after two chemotherapy cycles and by 38% after surgery to remove a kidney. Despite these changes, no child experienced serious kidney issues by the end of treatment, and doctors adjusted the chemotherapy dose to protect their kidneys. Who this helps: This helps children with Wilms tumor and their doctors by ensuring safer treatment options.

Plain English
This study focused on retinoblastoma, a type of eye cancer that can be cured if detected early and treated properly, but many children in developing countries suffer because they often receive delayed or inadequate care. It highlighted that while the death rate from this cancer is high in poorer regions, sharing knowledge and resources between healthcare centers in rich and developing countries can improve diagnosis and treatment. Successful strategies include creating partnerships and supporting local cancer treatment centers to ensure better outcomes for these kids. Who this helps: This helps children with retinoblastoma and their families in developing countries.

Plain English
This study examined the risk of developing a second cancer after treating Hodgkin's lymphoma with different methods: radiotherapy alone, chemotherapy alone, and a combination of both. The researchers found that patients who received combined chemotherapy and radiotherapy had a lower risk of developing a second cancer (about 22% less) compared to those who only had radiotherapy. However, using radiation to a larger area increased the risk of breast cancer significantly, suggesting that targeted treatments can help lower risks. Who this helps: This information benefits patients with Hodgkin's lymphoma and their doctors when deciding on treatment options.

Plain English
This study looked at how children's cancer pain is managed in two hospitals in Morocco. Researchers found that healthcare workers are very concerned about the pain these children experience, but they lack proper training and resources, making it hard to provide effective relief. There is also a need to change attitudes towards pain management, as some believe children should endure suffering. These findings highlight a serious gap in care and the urgent need for better guidelines to help doctors and nurses manage pain effectively. Who this helps: This benefits children with cancer and the healthcare professionals who care for them.

Plain English
This study looked at 168 children in Honduras with acute lymphoblastic leukemia, a type of blood cancer. It found that many stopped their treatment, which was the main reason for poor outcomes, especially if they lived far away from medical facilities or were younger than 4.5 years. Improving transportation, creating local treatment options, and better managing infections could greatly enhance survival rates for these children. Who this helps: This helps children with leukemia and their families in resource-poor areas.

Plain English
This study looked at how accurately blood tests for clotting factors (PT, aPTT, and fibrinogen) work when blood is drawn from specialized devices used in kids with cancer compared to traditional venipuncture. Researchers tested samples from 53 children and found that blood drawn from these devices gave significantly different results—indicating that this method is unreliable for assessing blood coagulation. It's crucial to know this because using these results could lead to incorrect treatment decisions. Who this helps: This helps doctors and healthcare providers working with pediatric cancer patients.

Plain English
This study focused on improving the training of nurses who care for children with blood cancers in Latin America, where healthcare resources can be limited. Since 1996, a program, initiated by St. Jude Children's Research Hospital, has successfully trained 76 nurses from various countries in the region through a structured curriculum and hands-on support. The improvements in nursing education can lead to better care for children with cancer, making sure all kids receive quality treatment no matter their circumstances. Who this helps: This benefits nurses, pediatric oncology patients, and overall healthcare systems in Latin America.

Plain English
This study examined a rare and aggressive kidney cancer called renal medullary carcinoma, specifically in a 10-year-old boy who has sickle cell trait. The researchers found that this type of cancer is often associated with sickle cells in the tissue and should be considered when young patients with sickle cell trait experience blood in their urine. This is important because early recognition of this cancer can lead to better outcomes for affected children. Who this helps: This benefits children with sickle cell trait and their doctors.

Plain English
This study focused on a rare condition called transient erythroblastopenia of childhood (TEC), which can sometimes be linked to temporary neurological issues. Researchers presented the case of a 20-month-old girl who experienced both TEC and temporary weakness on one side of her body, known as hemiparesis, which improved within 24 hours. Out of seven other patients with TEC, only one had neurological problems, but all recovered fully within a month, indicating that while neurological issues can occur with TEC, they are rare and not long-lasting. Who this helps: This information is beneficial for doctors and parents of young children with TEC, as it reassures them about the nature and resolution of the condition.

Plain English
Researchers studied whether a genetic mutation called factor V Leiden is linked to blood clotting problems (thrombosis) in children with cancer undergoing chemotherapy. They examined 67 children and found that only 1 out of 32 children with thrombosis had the mutation, while none of the 35 children without thrombotic issues had it. This means that the factor V Leiden mutation isn’t a major factor contributing to blood clots in these young cancer patients. Who this helps: This information benefits doctors and healthcare providers treating children with cancer.

Plain English
The study looked at how the speed of platelet transfusions affects both the quality of the platelets and how children with cancer feel during and after the treatment. Researchers tested different rates of infusion and found that the faster infusion doesn't harm platelet recovery or patient comfort, and it can cut the transfusion time in half. This matters because it allows for quicker treatment without sacrificing safety, meaning kids can spend less time in the clinic and get more available resources for other treatments. Who this helps: This helps children with cancer needing platelet transfusions, as well as the medical staff treating them.

Plain English
This study looked at how parents react when their child’s cancer comes back for the first time. Researchers interviewed 33 guardians and found four main responses: dealing with shock, staying informed about the situation, adjusting their feelings, and considering end-of-life care options. Understanding this process is important because it helps identify how parents can cope with extreme emotions and make informed decisions about their child's treatment while facing the harsh realities of the situation. Who this helps: This helps parents of children with cancer as well as healthcare providers supporting them.

Plain English
This study looked at how different treatments—radiation therapy, chemotherapy, and surgery—affect children with Wilms tumor in both kidneys at the same time. Researchers reviewed the cases of 38 children and found that 87% of the treatment sites remained under control, with the best results in early-stage disease where local control was nearly perfect (11 out of 11 without radiation and 10 out of 12 with radiation). These findings are important because they show that using a combination of effective treatments can help manage this complex condition without significantly compromising kidney function. Who this helps: This helps children with Wilms tumor and their doctors in making treatment decisions.

Plain English
The study looked at eight children with cancer who developed a condition called small-bowel intussusception after abdominal surgery. This condition happened in 2.2% of all pediatric cancer patients who had similar surgeries over 13 years. Timely diagnosis and treatment are crucial because this complication can be very serious, but can be effectively managed when caught early. Who this helps: This helps pediatric cancer patients and their doctors by highlighting an important risk following surgery.

Plain English
This study reports on a young patient with a blood disorder called sickle-beta+ thalassemia who experienced a serious condition known as fat embolism syndrome, which can occur when fat droplets enter the bloodstream. The patient initially had bone pain, but their condition quickly worsened, leading to confusion, trouble breathing, and ultimately death from heart and lung failure. This highlights the severe risks associated with sickle-beta thalassemia and the importance of early recognition and treatment. Who this helps: This information is valuable for doctors treating patients with sickle-beta thalassemia.

Plain English
This study looked at how children with moderate aplastic anemia (MAA) fared compared to those with severe aplastic anemia (SAA) over the past 12 years. They found that all 12 children with MAA are still alive after an average of 7 years, and more than half of them didn't need aggressive treatment, while only 5 progressed to the more severe condition, SAA. This is important because it shows that the outlook for children with MAA is much better than for those with SAA. Who this helps: This helps children diagnosed with moderate aplastic anemia and their families.

Plain English
This study looked at how different methods of delivering platelet transfusions affect the platelets' quality and how well they work in children with cancer. Researchers tested both infusion pumps and gravity flow methods, finding no significant differences in platelet counts or quality across these methods. This is important because it confirms that using infusion pumps for transfusions is safe and effective, helping nurses manage the process more efficiently. Who this helps: This helps doctors and nurses working with children undergoing cancer treatment.

Plain English
This study investigated how effective and safe a combination of chemotherapy and low-dose radiation treatment is for children and adolescents with Hodgkin's disease. Out of 85 patients treated, 93% remained free of disease after an average of over four years. While most patients did well, some experienced side effects, including breathing problems in 58% and thyroid issues in 27%. Who this helps: This research benefits patients with Hodgkin's disease and their doctors by providing effective treatment options with manageable side effects.

Plain English
This study focused on how increasing doses of the chemotherapy drug carboplatin, combined with ifosfamide and etoposide, affects children with recurrent solid tumors. The researchers found that higher doses led to significant side effects like low blood cell counts, but at a dose of 6 mg/mL x min, they recorded two complete responses and 13 partial responses among the patients treated, indicating the treatment could be effective. These findings are important because they lay the groundwork for future trials that could improve treatment options for these young patients. Who this helps: This helps children with relapsed solid tumors and their doctors.

Plain English
Researchers studied the effects of the chemotherapy drug ifosfamide given daily for three days to 29 children with certain aggressive tumors. They found that a safe starting dose was 2,133 mg/m² per day for those who had previously received similar treatments, while a higher dose of 3,000 mg/m² per day was safe for those who had not. These findings are important because they help determine how to use ifosfamide more effectively and safely in children with cancer. Who this helps: This benefits children with malignant solid tumors and their doctors managing their treatment.

Plain English
This study looked at how many patients with Hodgkin's disease experienced allergic reactions to a drug called etoposide when treated with a specific chemotherapy regimen. Out of 45 patients, 51% (23 patients) had allergic reactions, usually occurring within 5 minutes of starting the infusion. Even though many had reactions, 78% were able to safely receive etoposide again after taking precautions. Who this helps: This helps young patients facing Hodgkin's disease and their doctors.

Plain English
This study measured a protein called intercellular adhesion molecule-1 (ICAM-1) in the blood of children diagnosed with various cancers, including Hodgkin's disease and leukemia. Scientists found that levels of ICAM-1 were much higher in children with Hodgkin's disease and acute lymphoblastic leukemia compared to healthy children, and higher levels were linked to more advanced disease stages and relapses in Hodgkin's disease. Understanding these levels may help doctors better track cancer progress and make treatment decisions. Who this helps: This helps doctors and pediatric cancer patients by providing potential indicators of disease severity and treatment response.

Plain English
This study looked at levels of a substance called interleukin-2 receptor (IL2R) in the blood of children with different types of cancer, including Hodgkin disease. It found that higher levels of IL2R were linked to more advanced stages of Hodgkin disease and that very high levels (over 5000 U/ml) were associated with worse treatment outcomes. This information could help doctors better assess the risk of poor treatment responses in children with Hodgkin disease, allowing for more tailored treatment plans. Who this helps: This helps doctors and patients with Hodgkin disease.

Plain English
This study looked at the outcomes of 36 children with bilateral Wilms tumor, a type of kidney cancer, treated over 28 years at St. Jude Children's Research Hospital. It found that 71% of patients with tumors appearing at different times survived, similar to the 70% survival rate of those with tumors appearing at the same time. Most patients had few long-term complications, suggesting that personalized treatment can lead to good outcomes with minimal late effects. Who this helps: This research benefits pediatric cancer patients and their doctors by highlighting effective treatment approaches and expected outcomes.

Plain English
This study looked at a rare blood condition called myeloid neoplasia in children who were treated for solid tumors. Out of 3,365 children, 12 developed this condition 14 to 189 months after their initial cancer diagnosis, leading to a low risk of about 1.2% to 1.3% for those with specific cancers like Hodgkin's disease, non-Hodgkin lymphoma, and neuroblastoma. Understanding the factors that increase this risk, such as certain treatments and age, helps doctors manage and monitor patients more effectively. Who this helps: This helps pediatric oncologists and their patients who have survived solid tumors.

Plain English
This study looked at 52 children with a specific type of kidney cancer called Wilms' tumor, who still had cancer left after surgery. Researchers wanted to see if a lower amount of radiation would still be effective when combined with chemotherapy. They found that after two years, 85% of children with Stage III and 71% of those with Stage IV were cancer-free, indicating that the treatment worked well while using less radiation, which is safer for the patients. Who this helps: This benefits children with Wilms' tumor and their families by providing effective treatment options that reduce exposure to harmful radiation.

Plain English
This study looked at a protein called CD8 in the blood of 90 children diagnosed with Hodgkin's disease to understand its relationship with disease severity and treatment success. The researchers found that children with advanced stages of the disease had higher CD8 levels (675 U/mL for stage III or IV) compared to those with early stages (477 U/mL for stage I or II), and high CD8 levels were linked to a greater chance of treatment failing (with levels over 430 U/mL being significant). These findings matter because they suggest that measuring CD8 levels could help doctors predict how well a child's treatment might work. Who this helps: This helps doctors in treating children with Hodgkin's disease.

Plain English
This study focused on a rare type of Wilms' tumor that occurs outside of the kidneys, known as extrarenal Wilms' tumor. Researchers reviewed a total of 19 documented cases and described three new patients, two of whom also had horseshoe kidneys. They found that understanding the connection between these tumors and horseshoe kidneys can help doctors make a quicker diagnosis and ensure patients receive the right treatment, similar to standard therapies for kidney-based Wilms' tumors. Who this helps: This helps doctors by improving diagnosis and treatment options for children with these rare tumors.

Plain English
This study looked at how levels of a protein called interleukin-2 receptor (IL2R) in the blood relate to the outcomes of children with Hodgkin's disease. They found that children with advanced stages of the disease (stages III and IV) had much higher IL2R levels (3,195 U/ml) compared to those with earlier stages (1,087 U/ml), indicating a poorer prognosis. Children with very high IL2R levels (5,000 U/ml or more) were also more likely to have treatment failures. Who this helps: This information helps doctors better understand which children may face more serious challenges with their Hodgkin's disease treatment.

Plain English
This study looked at a rare type of kidney tumor called teratoid Wilms' tumor in children, analyzing samples from 290 patients treated at St. Jude Children's Research Hospital. Out of these, three children were found to have this tumor, with two of them experiencing severe complications and not responding well to chemotherapy, while one child unfortunately passed away due to related health issues. The findings highlight that surgery is usually the best treatment option for these tumors because they often lead to complications and don't respond to standard treatments as well as typical Wilms' tumors. Who this helps: This benefits children diagnosed with teratoid Wilms' tumor and their doctors by providing clearer treatment guidelines.

Plain English
This study examined the effects of ifosfamide/mesna treatment on 50 children with cancer. Out of these patients, 11 showed signs of temporary brain-related issues like changes in mental status and seizures during 29 treatment sessions. These findings are important because they help medical professionals identify when to pause or stop treatment to avoid serious neurological side effects. Who this helps: This helps doctors and pediatric cancer patients by providing guidelines for safer treatment decisions.

Plain English
This study looked at the imaging techniques used to diagnose cystic kidney tumors in four children. The researchers found that while CT scans and ultrasounds provided helpful information, they could not definitively identify the tumors' nature before surgery. To ensure accurate diagnosis and treatment, they recommend comprehensive imaging followed by kidney removal for all cases of these tumors in young patients. Who this helps: This helps children with cystic kidney tumors and their doctors.

Plain English
Researchers studied how the spleen works in patients with different types of sickle cell disorders. They found that in sickle cell anemia and a related condition, splenic problems usually appear in the first year of life for 13.5% of patients, while another type, hemoglobin S beta(+) thalassemia, shows splenic issues less often and later on. Understanding these patterns is important because it helps identify when young patients are at higher risk for severe infections. Who this helps: This helps doctors and patients with sickle cell disorders manage their risk for infections.

Plain English
This study looked at the immune system of ten children with sickle cell disease who regularly receive blood transfusions and compared them to other groups, such as children with sickle cell who do not get transfusions and healthy adults. Researchers found normal levels of certain immune cells (helper:suppressor T cells) in all groups except those with hemophilia, while sickle cell patients showed lower levels of specific T cells and higher IgG levels, indicating unique immune reactions. This matters because it highlights that transfused sickle cell patients have different immune patterns than those typically seen in other serious conditions, which can guide more tailored medical care. Who this helps: This helps doctors and healthcare providers in better managing immune health in children with sickle cell disease.

Plain English
Researchers studied a 2-year-old girl who had both Wilms tumor (a type of kidney cancer) and a large kidney stone at the same time. They found that she had tumors in both of her kidneys along with a significant kidney stone on one side. This is important because it highlights a rare situation where a child deals with both a serious cancer and a kidney stone, which could affect treatment decisions. Who this helps: This helps doctors diagnose and treat young patients with similar conditions.

Plain English
This study looked at the cells in the blood called neutrophils from two brothers who have a condition known as cyclic neutropenia. They found that throughout the 15 to 21-day cycle of neutrophil levels, many of the neutrophils looked normal, but there were significant abnormalities at different stages, especially in the early part of the cycle, which included signs of cell damage and unusual structures in the cells. These findings are important because they show a pattern of damage happening to the cells that produce neutrophils, which can help doctors better understand and treat this condition. Who this helps: This helps patients with cyclic neutropenia and their doctors.

Plain English
This study looked at proteins that bind to a molecule called cAMP in Wilms' tumor tissue and compared them to those in normal kidney tissue. Researchers found that tumor samples had a significantly higher ratio of type I to type II cAMP-binding proteins, with an average of 2.76 in tumors versus 1.36 in normal kidneys (a very strong difference with a p-value of less than 0.001). This matters because it shows that Wilms' tumors have a distinctive protein profile that could help understand how the tumor functions and potentially guide treatment strategies. Who this helps: This helps doctors and researchers who focus on treating and understanding Wilms' tumor in children.

Plain English
This study looked at how often hydroceles, which are fluid-filled sacs in the scrotum, occur in men who were treated for Hodgkin's disease. Out of 155 patients, 12 (about 8%) developed hydroceles after their treatment, typically between 8 months and 7.5 years later. The study found that these complications were related to damage in the lymphatic system from radiation therapy, which may lead to severe tissue scarring. Who this helps: This information is useful for doctors treating male patients with Hodgkin's disease, helping them be aware of potential complications after radiation therapy.

Plain English
The study looked at the immune systems of six patients with Evans syndrome, a condition that includes both anemia and low platelet counts, and compared them to seven patients with chronic immune thrombocytopenic purpura (ITP). The researchers found that those with Evans syndrome had fewer helper T-cells, more suppressor T-cells, and a big difference in the balance between these types of cells compared to the other group. This imbalance suggests that the immune system of Evans syndrome patients is not functioning properly, which may explain their ongoing health issues. Who this helps: This helps patients with Evans syndrome, as well as their doctors, by providing insights into their immune system's challenges.

Plain English
This study looked at a 10-year-old girl with hereditary elliptocytosis who experienced changes in her red blood cells during an episode of acute hepatitis. The researchers found that during this illness, there was an increase in red blood cell breakdown and abnormal shapes of the cells. This matters because it highlights how liver problems can affect blood cell health in patients with certain genetic conditions. Who this helps: Patients with hereditary elliptocytosis and their doctors.

Plain English
Researchers studied Wilms' tumors, a type of kidney cancer in children, using a new method to break down the tumors into single cells. They found that this improved technique allowed for better cell viability—ranging from 56% to 100%—and successfully generated tumor colonies, showing that the method is effective and specific for cancer cells. Specifically, they generated a high number of colonies from the tumor cells, which could enhance future cancer research and treatment approaches. Who this helps: This benefits doctors and researchers working on treatments for pediatric cancer.

Plain English
This study looked at how to treat priapism, a painful condition where the penis remains erect for a long time, in children with sickle cell anemia. The researchers successfully treated 5 children by creating a small channel between the tip of the penis and the erectile tissue, with no complications reported. This finding is important because it shows that a common surgical method can benefit children with sickle cell anemia who experience priapism, which is often overlooked in this patient group. Who this helps: This helps children with sickle cell anemia who suffer from priapism.

Plain English
This study looked at the effects of blood transfusion therapy in children with sickle cell disease who had experienced strokes. Researchers found that after one to two years of transfusions, stopping the treatment led to seven out of ten patients having another stroke, with the average time until this second stroke being three months. This matters because it shows that while transfusions may help during treatment, they do not prevent future strokes once they are stopped. Who this helps: This information is valuable for doctors treating children with sickle cell disease and stroke.

Plain English
This study looked at a rare combination of blood disorders in children called Evans syndrome, which includes conditions where the body mistakenly destroys its own blood cells. Out of 164 cases of one disorder and 15 of another, 11 children were found to have Evans syndrome, which often leads to ongoing health issues. The treatments currently available, like steroids and surgeries, do not work well, making it important to better understand this condition and its effects. Who this helps: This research benefits doctors and healthcare providers treating pediatric patients with complex blood disorders.

Plain English
This study looked at the long-term effects of treating 54 children and teenagers with Hodgkin's disease between 1967 and 1972. It found that 70% of the patients are still cancer-free today, but some faced serious health issues, including growth problems, especially among boys who had radiation therapy before age 16. Understanding these long-term effects can help improve treatment while still effectively curing the disease. Who this helps: This benefits patients and their families by improving treatment approaches.

Plain English
This study looked at three patients with Fanconi's anemia who were treated with androgen-anabolic steroids for a condition called aplastic anemia. Researchers found that after at least 42 months of treatment, these patients experienced changes in their pancreas, leading to difficulty managing blood sugar levels and also had benign tumors in the liver. The findings highlight how androgen therapy can affect both the pancreas and liver, which is important for understanding potential complications in these patients. Who this helps: This research benefits patients with Fanconi's anemia and their doctors by informing them about risks associated with androgen therapy.

Plain English
This study looked at blood tests, specifically serum copper levels and erythrocyte sedimentation rates, in 29 children with Hodgkin's disease to see if they could accurately indicate how active the disease was. The findings showed that serum copper levels were not reliable, as many children in remission also had high levels, making it hard to tell if they were healthy or not. While the erythrocyte sedimentation rate was often high in children whose disease returned, it was also high in many children without the disease, making it a poor early warning sign. Who this helps: This research benefits doctors treating children with Hodgkin's disease by highlighting that certain blood tests may not be reliable indicators of disease activity.